Skip to content
★ Sign in to follow
NR

New Ray Medicine International Holding Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$46.3MHealth Care

No insider purchase over the last 90 days. The latest, by Chu Xueping, was filed 27 Jul 2023.

New Ray Medicine International Holding Ltd.: what insiders have been doing

New Ray Medicine International Holding Ltd. is a Health Care company. Its directors and officers file their transactions with HKEX. The last twelve months, up to 22 October 2026, brought 1 filing signed by 1 insider.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Insider buying of New Ray Medicine International Holding Ltd. has been absent for the past year.

For context, the typical company on the same exchange (median of 1,314 companies) published 4 filings over the same period, against 1 filing here. The full history, which starts in 2018, counts 3 purchases against no sales.

Elsewhere in the same sector, our signals recently picked up insider purchases at UCB. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.

Insider Decl.
7
Thresholds
n/a
Buy Volume
n/a
3 ops. · all time
Sell Volume
n/a
n/a
Fundamental score
Ranked 26,278 of 26,897 companies
10.6
score / 100
Value
5
Quality
16
FCF yld-79%
Earn yld-29%
EV/EBITDA·
ROE-3.8%
Gross mgn12%
Net mgn-15%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$0.23
Analyst consensus
·
Income statement
RevenueHK$130.4M
Gross profitHK$16.1M12% margin
EBITDA-HK$16.3M-12% margin
Net income-HK$20.1M-8.1% margin
Valuation
P/Book0.1x
Beta-3.90
Balance sheet & cash
Market capHK$46.3M
Total debtHK$2.5M
Free Cash Flow-HK$54.5M
Debt / Equity0%
Profitability & ownership
ROE-3.8%
ROA-1.8%
% insiders29.3%
% institutions0.0%
Last declaration on 15 October 2026
Declarations7 total
  • ●
    DirectorExecutives
    0HKEX
    1,660,000 sharesShareXHKGHKEX:DA20261015E00047
  • ▲
    DirectorExecutives
    0HKEX
    426,672,000 sharesShareXHKGHKEX:DA20230727E00388
    Canonical exit: 23 Oct 2023 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    15,000,000 sharesShareXHKGHKEX:DA20230403E00193
  • ▲
    DirectorExecutives
    0HKEX
    16,600,000 sharesShareXHKGHKEX:DA20220616E00177
    Canonical exit: 12 Sept 2022 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    16,600,000 sharesShareXHKGHKEX:DA20220616E00172
    Canonical exit: 12 Sept 2022 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    112,728,000 sharesShareXHKGHKEX:DA20180704E00031
  • ●
    DirectorExecutives
    0HKEX
    112,728,000 sharesShareXHKGHKEX:DA20180704E00028

7 of 7 declarations

About New Ray Medicine International Holding Ltd.

New Ray Medicine International Holding Ltd. is a company focused on the development and distribution of pharmaceutical products. It emphasizes innovation in the healthcare sector.